Page last updated: 2024-11-04

roxarsone and Obesity

roxarsone has been researched along with Obesity in 1 studies

Roxarsone: An arsenic derivative which has anticoccidial action and promotes growth in animals.
roxarsone : An organoarsonic acid where the organyl group is 4-hydroxy-3-nitrophenyl.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sekar, A1
Simon, J1
Taliercio, J1

Other Studies

1 other study available for roxarsone and Obesity

ArticleYear
Adult-Onset Proximal Tubule Dysfunction.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018, Volume: 71, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Arsenic; Diagnosis, Differential; Diet, Reducing; Dietary Proteins;

2018